Pnc Financial Services Group, Inc. Kala Pharmaceuticals, Inc. Transaction History

Pnc Financial Services Group, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.3 - $1.31 $64 - $282	-216 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$1.16 - $2.74 $556 - $1,315	-480 Reduced 68.97%	216 $0
Q1 2020 May 08, 2020	BUY	$3.83 - $8.79 $306 - $703	80 Added 12.99%	696 $6,000
Q4 2019 Feb 07, 2020	BUY	$3.36 - $4.81 $221 - $317	66 Added 12.0%	616 $2,000
Q2 2019 Aug 09, 2019	SELL	$4.93 - $8.8 $211 - $378	-43 Reduced 7.25%	550 $0
Q1 2019 May 10, 2019	BUY	$5.19 - $8.97 $223 - $385	43 Added 7.82%	593 $0
Q4 2018 Feb 08, 2019	BUY	$4.29 - $9.94 $858 - $1,988	200 Added 57.14%	550 $2,000
Q4 2017 Feb 09, 2018	BUY	$13.68 - $23.17 $4,788 - $8,109	350	350 $0

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $8.67M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.